Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.9 CHF | +0.76% | -0.87% | +13.03% |
07:15am | Basilea Reports Presentation of New Data for Ceftobiprole (Zevtera®) At Escmid Global 2024 | CI |
Apr. 09 | Basilea Pharmaceutica Receives Grant for Antibiotics Program | MT |
- Stock Market
- Equities
- BSLN Stock
- News Basilea Pharmaceutica AG
- Other languages